Clinical trial NCT05803434
Status: Active, not recruitingPhase 2Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy
- Record number
- NCT05803434
- Status
- Active, not recruiting
- Type and phase
- Clinical trial, phase 2
- Participants
- Target: 30
- Condition (as registered)
- Epilepsy, Rare Diseases
- Countries
- Italy
- Topic in the guide
- Drug-Resistant Epilepsy
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: March 14, 2024
- End of data collection for primary results: April 1, 2026
- Trial completion: December 1, 2026 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Active, not recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Drug-Resistant Epilepsy: ongoing trials · Thinking of taking part? Which specialist to see